-0% Off

Ibrance (Palbociclib)

Original price was: $13,010.00.Current price is: $13,000.00.

Ibrance’s active ingredient is Palbociclib. Administered orally through capsules or tablets, it comes in three strengths: 75mg, 100mg, and 125mg.

Ibrance is a targeted therapy for this type of breast cancer, slowing and targeting the growth of cancer cells, which otherwise multiply uncontrollably.

Compare
Category:

Description

Ibrance is an exclusively branded prescription medication; presently, no generic equivalent exists. It serves adults with advanced breast cancer, specifically:

  • Cancer that has spread or is advanced/metastatic.
  • Hormone receptor-positive cancer (stimulated by estrogen/progesterone).
  • HER2-negative cancer (normal HER2 protein levels).

Ibrance, alongside specific hormone therapies, is prescribed. Hormone therapy curbs estrogen’s cancer-stimulating effects.

Both genders can use Ibrance in specific cases.

Ibrance’s active ingredient is Palbociclib. Administered orally through capsules or tablets, it comes in three strengths: 75mg, 100mg, and 125mg.

Ibrance is a targeted therapy for this type of breast cancer, slowing and targeting the growth of cancer cells, which otherwise multiply uncontrollably.

Additional information

Usage

Usage
-Palbociclib is administered orally through capsules. Generally, take it with food once daily for the first 21 days of a 28-day cycle. Your doctor will determine the number of cycles needed. Consistency is key—consume palbociclib at roughly the same time daily. Comply diligently with your prescription's instructions, and seek clarification from your doctor or pharmacist for any uncertainties. Strictly adhere to the prescribed regimen—neither exceeding nor reducing dosage frequency. Swallow capsules whole, without opening, chewing, or crushing. Avoid damaged capsules. If vomiting occurs after consumption, abstain from an additional dose; maintain your regular schedule. Your doctor may adjust or halt your palbociclib dose gradually if specific side effects manifest. Maintain open communication with your doctor regarding your treatment journey. For detailed patient information, consult your pharmacist or doctor.

Side Effects

Side Effects
Ibrance may lead to either mild or severe side effects. Below is a list of potential side effects, though it's important to note that not all possible effects are listed.
Discuss potential Ibrance side effects with your doctor or our pharmacists. If you encounter bothersome side effects, they can offer advice on managing them.
Ibrance might result in the following side effects:
• Anemia (low red blood cell count)
• Thrombocytopenia (low platelet levels)
• Fatigue (low energy)
• Viral infections
• Vomiting and nausea
• Diarrhea
• Hair loss or thinning
• Mouth sores or pain
• Anxiety
• Reduced appetite
• Skin rash
• Changes in liver function tests (possible liver damage)
• Weakness (asthenia)
• Flu-like symptoms
Serious side effects can also arise from Ibrance. If you experience such effects, promptly contact your doctor. In situations of life-threatening danger or medical emergencies, dial 911.
The following are serious side effects and their associated symptoms:
• Pulmonary inflammation or scarring
• Breathing difficulties
• Coughing
Pulmonary embolism, a blockage caused by a blood clot in the lungs, can lead to these symptoms:
• Breathing difficulties
• Chest pain
Neutropenia, characterized by low levels of specific white blood cells, can cause the following conditions:
• Low levels of certain white blood cells.

Storage

Storage
-Store this medication in its original container, tightly sealed, and out of children's reach. Keep it at room temperature, avoiding excessive heat and moisture (not in the bathroom). Proper disposal is crucial to prevent accidental consumption by pets, children, or others. Never flush this medication down the toilet. Instead, opt for a medicine take-back program. Consult your pharmacist or local waste management for such programs. Safeguard all medications from children by using child-resistant containers. Lock safety caps and store medicines in an elevated, inaccessible location.

Precaution

Precaution
Before you begin taking palbociclib, read the Patient Information Leaflet provided by your pharmacist, if available, and consult your doctor or one of our pharmacists if you have any queries.
Your doctor will guide you to take this medication once daily for 21 days, followed by a 7-day break. This forms a treatment cycle, and you should continue as directed.
Palbociclib is available as capsules or tablets. Take capsules with food, and tablets can be taken with or without food. Swallow them whole; do not chew, crush, open, or split.
Avoid using broken or damaged capsules or tablets. If you vomit after taking a dose, do not take another dose that day. Resume with the next scheduled dose on the following day.
Your dosage is determined by your medical condition, lab results, treatment response, and other medications. Inform your doctor and pharmacist about all your medications, including prescriptions, over-the-counter drugs, and herbal products. If you experience side effects, your doctor may adjust your dosage or temporarily stop treatment. For detailed information, consult your doctor.
While using this medication, refrain from consuming grapefruit or its juice unless advised by your doctor or pharmacist. Grapefruit can cause adverse effects with this medicine. For more guidance, consult your healthcare provider.
To derive maximum benefits, use this medication consistently and take it at the same time each day.
Adhere strictly to your prescribed dosage. Do not increase, prolong, or overuse the medication. Neither will these actions accelerate your condition's improvement nor reduce your risk of severe side effects.
Pregnant women or those planning pregnancy should not handle palbociclib or inhale its dust, as it may pose risks to an unborn child through skin absorption and inhalation.

Reviews

There are no reviews yet.

Be the first to review “Ibrance (Palbociclib)”

Your email address will not be published. Required fields are marked *